---
figid: PMC6134416__zgfazz-13-11-C46-3
figtitle: 在SCLC中，受体酪氨酸激酶及其配体通常呈过表达状态。缺陷性受体酪氨酸激酶及它们各自的生长因子包括：VEGFR/VEGF, c-Kit/SCF,
  c-MET/HGF, FGFR/FGF以及IGF-1R/IGF。通过多种通路的激活，包括在SCLC中失调的PI3K/AKT/mTOR通路，在存活、凋亡、细胞周期调节和翻译过程中发挥作用。Receptor
  tyrosine kinases and their known ligands are often overexpressed in SCLC
organisms:
- NA
pmcid: PMC6134416
filename: zgfazz-13-11-C46-3.jpg
figlink: /pmc/articles/PMC6134416/figure/Figure3/
number: F3
caption: 在SCLC中，受体酪氨酸激酶及其配体通常呈过表达状态。缺陷性受体酪氨酸激酶及它们各自的生长因子包括：VEGFR/VEGF, c-Kit/SCF,
  c-MET/HGF, FGFR/FGF以及IGF-1R/IGF。通过多种通路的激活，包括在SCLC中失调的PI3K/AKT/mTOR通路，在存活、凋亡、细胞周期调节和翻译过程中发挥作用。Receptor
  tyrosine kinases and their known ligands are often overexpressed in SCLC. Defective
  receptor tyrosine kinases and their respective growth factors in SCLC include VEGFR/VEGF,
  c-Kit/ SCF, c-MET/HGF, FGFR/FGF and IGF-1R/IGF. Through activation of multiple pathways,
  including the PI3K/AKT/mTOR pathway that also is known to be dysregulated in SCLC,
  they are involved in survival, apoptosis, cell cycle regulation and translation.
papertitle: 小细胞肺癌的的分子发病机制.
reftext: Sandra P. D'ANGELO, et al. Zhongguo Fei Ai Za Zhi. 2010 Nov 20;13(11):C46-C57.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.963878
figid_alias: PMC6134416__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC6134416__F3
ndex: b841f56a-dec7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6134416__zgfazz-13-11-C46-3.html
  '@type': Dataset
  description: 在SCLC中，受体酪氨酸激酶及其配体通常呈过表达状态。缺陷性受体酪氨酸激酶及它们各自的生长因子包括：VEGFR/VEGF, c-Kit/SCF,
    c-MET/HGF, FGFR/FGF以及IGF-1R/IGF。通过多种通路的激活，包括在SCLC中失调的PI3K/AKT/mTOR通路，在存活、凋亡、细胞周期调节和翻译过程中发挥作用。Receptor
    tyrosine kinases and their known ligands are often overexpressed in SCLC. Defective
    receptor tyrosine kinases and their respective growth factors in SCLC include
    VEGFR/VEGF, c-Kit/ SCF, c-MET/HGF, FGFR/FGF and IGF-1R/IGF. Through activation
    of multiple pathways, including the PI3K/AKT/mTOR pathway that also is known to
    be dysregulated in SCLC, they are involved in survival, apoptosis, cell cycle
    regulation and translation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - IGF1
  - KITLG
  - HGF
  - IL6
  - SOS1
  - KDR
  - FLT1
  - FLT4
  - IGF1R
  - KIT
  - MET
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - PTEN
  - MTOR
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - bnl
  - scf
  - blo
  - btl
  - htl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Pten
  - Mtor
  - Tor
  - CycE
  - cyc
  - Cancer
---
